Regeneron Director Huda Y. Zoghbi Reports Disposal of $7.22 Million in Common Shares

• Regeneron Pharmaceuticals director Huda Y. Zoghbi sold 7,439 common shares on November 3, 2026.
• Sales comprised 6,939 shares at $970.42 per share and 500 shares at $971.06 per share.
• Zoghbi exercised non-qualified stock options for 7,439 common shares at $380.95 per share.
• Direct beneficial ownership totaled 1,703 common shares following the transactions.
• The Form 4 was signed November 5, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001681643-26-000008), on November 05, 2026, and is solely responsible for the information contained therein.